… one-fifth of the patients are children and adolescents. Out of 463 MEFV mutation-specified …
trial to explore the safety and efficacy of anakinra in colchicine-resistant FMF patients. It was …

… achieved good outcomes about effectiveness and safety [20]. Anakinra and canakinumab
are … Anakinra and canakinumab succeeded in complete remission in more than two-third of …

… case series of colchicine-resistant Familial Mediterranean fever patients who … Anakinra in
two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever…

… -1 receptor antagonist anakinra for colchicine-resistant FMF … series of colchicine-resistant
Familial Mediterranean fever patients … nine adolescent and adult FMF patients. They treated the …

… Anakinra is proven to be effective in controlled trials in terms of attack frequency and subclinical
inflammation in colchicine-resistant … The effectiveness of anakinra stems from preventing …

… anakinra before canakinumab in 14 of 19 crFMF patients with a mean duration of 6 months
and have seen that anakinra … Efficacy of antiIL-1 treatment in familial Mediterranean fever: a …

… in colchicine resistant/intolerant patients. In this study we investigated long-term efficacy and
safety of anakinra and … Efficacy and safety of canakinumab in adolescents and adults with …

… Anakinra for colchicine-resistant familial Mediterranean fever: a … Efficacy and safety of
canakinumab in adolescents and … in colchicine resistant familial Mediterranean fever cases. Front …

… side effects [both situations are referred to as colchicine-resistant FMF (crFMF)]. Untreated
or … Data for the efficacy of anakinra were available from one RCT [18] and for effectiveness …

… efficacy of anti-IL-1 agents in colchicine-resistant pediatric FMF patients, the experience of
using on-demand anakinra … Although a single-dose subcutaneous anakinra administration is …